Literature DB >> 12742595

Calorie restriction of a high-carbohydrate diet elevates the threshold of PTZ-induced seizures to values equal to those seen with a ketogenic diet.

Douglas A Eagles1, Suzanne Jabbour Boyd, Anandi Kotak, Fiona Allan.   

Abstract

The purpose of this study was to evaluate the contributions of ketonemia, caloric restriction, and carbohydrates to seizure protection in rats fed selected diets. Male Sprague-Dawley rats were fed experimental diets of two basic types, one high in carbohydrates and restricted to 90, 65, or 50% of the normal daily caloric requirement and the other a normal rodent chow diet restricted to 90 or 65% of the daily caloric requirement. After consuming their respective diets for 20 days, animals were subjected to tail-vein infusion of pentylenetetrazole (PTZ) to determine seizure threshold, taken as the dose required to evoke the first clonic reaction. Seizure thresholds were compared to those of rats fed control diets of either normal rodent chow fed ad libitum or a standard high-fat (ketogenic) diet calorie-restricted to 90% of daily caloric requirement, all animals age- and weight-matched at the time of diet onset. All diets were balanced for vitamins and minerals and contained at least 10% protein (by weight). Seizure threshold and ketonemia were elevated in both experimental diets in approximate proportion to the degree of calorie restriction. Animals fed the most severely restricted high-carbohydrate diet (50%) had seizure thresholds equal to those fed the ketogenic diet but had significantly lower ketonemia.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12742595     DOI: 10.1016/s0920-1211(03)00041-x

Source DB:  PubMed          Journal:  Epilepsy Res        ISSN: 0920-1211            Impact factor:   3.045


  15 in total

1.  Eating your way to seizure control.

Authors:  Carl E Stafstrom
Journal:  Epilepsy Curr       Date:  2004 Jul-Aug       Impact factor: 7.500

2.  Dietary approaches to epilepsy treatment: old and new options on the menu.

Authors:  Carl E Stafstrom
Journal:  Epilepsy Curr       Date:  2004 Nov-Dec       Impact factor: 7.500

3.  Ketogenic diet decreases circulating concentrations of neuroactive steroids of female rats.

Authors:  Madeline E Rhodes; Jayanth Talluri; Jacob P Harney; Cheryl A Frye
Journal:  Epilepsy Behav       Date:  2005-09       Impact factor: 2.937

4.  Increased Hippocampal Afterdischarge Threshold in Ketogenic Diet is Accompanied by Enhanced Kynurenine Pathway Activity.

Authors:  Bartosz Osuch; Karolina Kołosowska; Natalia Chmielewska; Danuta Turzyńska; Alicja Sobolewska; Janusz Szyndler; Piotr Maciejak
Journal:  Neurochem Res       Date:  2022-05-06       Impact factor: 3.996

5.  Insights into the development of pentylenetetrazole-induced epileptic seizures from dynamic metabolomic changes.

Authors:  Xue Zhao; Peixuan Cheng; Ru Xu; Kaili Meng; Sha Liao; Pu Jia; Xiaohui Zheng; Chaoni Xiao
Journal:  Metab Brain Dis       Date:  2022-07-15       Impact factor: 3.655

Review 6.  Ketogenic ratio, calories, and fluids: do they matter?

Authors:  Elaine C Wirrell
Journal:  Epilepsia       Date:  2008-11       Impact factor: 5.864

Review 7.  The neuroprotective properties of calorie restriction, the ketogenic diet, and ketone bodies.

Authors:  Marwan Maalouf; Jong M Rho; Mark P Mattson
Journal:  Brain Res Rev       Date:  2008-09-25

Review 8.  The ketogenic diet and brain metabolism of amino acids: relationship to the anticonvulsant effect.

Authors:  Marc Yudkoff; Yevgeny Daikhin; Torun Margareta Melø; Ilana Nissim; Ursula Sonnewald; Itzhak Nissim
Journal:  Annu Rev Nutr       Date:  2007       Impact factor: 11.848

9.  Management of multifactorial idiopathic epilepsy in EL mice with caloric restriction and the ketogenic diet: role of glucose and ketone bodies.

Authors:  John G Mantis; Nicole A Centeno; Mariana T Todorova; Richard McGowan; Thomas N Seyfried
Journal:  Nutr Metab (Lond)       Date:  2004-10-19       Impact factor: 4.169

10.  Caloric restriction protects against electrical kindling of the amygdala by inhibiting the mTOR signaling pathway.

Authors:  Bryan V Phillips-Farfán; María Del Carmen Rubio Osornio; Verónica Custodio Ramírez; Carlos Paz Tres; Karla G Carvajal Aguilera
Journal:  Front Cell Neurosci       Date:  2015-03-11       Impact factor: 5.505

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.